Lombard Odier Asset Management (USA)’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,000
Closed -$775K 466
2022
Q3
$775K Buy
+15,000
New +$620K 0.02% 231

Other funds holding CCXI

Lombard Odier Asset Management (USA)'s CCXI Position: Q4 2022 in Review

Lombard Odier Asset Management (USA) sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 15,000 shares — an estimated $775K sold.

Lombard Odier Asset Management (USA) first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $775K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Lombard Odier Asset Management (USA) reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 15,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $775K.
  • Lombard Odier Asset Management (USA) first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • Lombard Odier Asset Management (USA)'s ChemoCentryx, Inc. position peaked at $775K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2022, filed 14 Feb 2023.